Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma (Q33554179)

28 July 2017

Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma (English)

1 reference

intrahepatic cholangiocarcinoma

28 July 2017

0 references

0 references

1 reference

Eduardo Barroso

9

0 references

Hugo P Marques

Hugo Marques

7

0 references

Christine Sempoux

Christine Sempoux

12

0 references

Timothy Pawlik

19

Timothy M Pawlik

1 reference

28 July 2017

16

Laura Rubbia-Brandt

1 reference

28 July 2017

6

Sorin Alexandrescu

1 reference

28 July 2017

Luca Antonio Aldrighetti

10

Luca Aldrighetti

1 reference

28 July 2017

Georgios C Sotiropoulos

4

Georgios C Sotiropoulos

1 reference

28 July 2017

Srinevas K Reddy

1

1 reference

28 July 2017

Omar Hyder

2

1 reference

28 July 2017

J Wallis Marsh

3

1 reference

28 July 2017

Andreas Paul

5

1 reference

28 July 2017

Carlo Pulitano

8

1 reference

28 July 2017

David A Geller

11

1 reference

28 July 2017

Vlad Herlea

13

1 reference

28 July 2017

Irinel Popescu

14

1 reference

28 July 2017

Robert Anders

15

1 reference

28 July 2017

Jean-Francois Gigot

17

1 reference

28 July 2017

Giles Mentha

18

1 reference

28 July 2017

25 January 2013

1 reference

Journal of Gastrointestinal Surgery

28 July 2017

1 reference

28 July 2017

17

1 reference

28 July 2017

4

1 reference

28 July 2017

748-755

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-013-2149-x

28 July 2017

0 references

cites work

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Human fatty liver disease: old questions and new insights

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Update on fatty liver disease and steatohepatitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Endpoints and clinical trial design for nonalcoholic steatohepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

An overview of nonalcoholic steatohepatitis: past, present and future directions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Prevalence, gender, ethnic variations, and prognosis of NASH.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Etiology of liver cirrhosis in Japan: a nationwide survey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007003

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Late nonalcoholic fatty liver disease with cirrhosis: a pathologic case of lost or mistaken identity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2149-X

Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C

21 January 2018

1 reference

12 December 2020

Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

1 reference

12 December 2020

Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study

1 reference

12 December 2020

Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis

1 reference

12 December 2020

The metabolic syndrome

1 reference

12 December 2020

10.1007/S11605-013-2149-X

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference